Can platelet-rich plasma (PRP) improve tissue support for laxity?

Detailed Medical Explanation

Can platelet-rich plasma (PRP) improve tissue support for laxity? PRP is prepared from your own blood and contains a higher concentration of platelets that release growth factors (e.g., PDGF, TGF-?, VEGF) when activated. In theory, these signals may encourage local collagen remodelling, microvascular support and mucosal comfort. In women describing mild, entry-focused laxity (a sense of gaping, air-trapping with activity, early-penetration discomfort), PRP is sometimes explored as an adjunct once foundations are in place. It does not replace pelvic floor muscle training, correct a malpositioned perineal scar, or treat prolapse beyond the introitus; and it is not a substitute for GSM care when dryness and sting are dominant.

Where PRP might fit. If you have completed a high-quality block of pelvic floor rehabilitation (activation, endurance, timing) and optimised GSM care (scheduled vaginal moisturiser, a generous compatible lubricant, and—if acceptable—local vaginal oestrogen) yet still notice reproducible, mechanical entry symptoms, PRP may be discussed alongside, or instead of, energy-based options. To see how we stage decisions and what to expect at each step, review what the treatment involves and how we progress care under treatment steps.

What the appointment is like. After consent and a safety screen, a small blood draw (typically 10–20 ml) is centrifuged to concentrate platelets. The area is cleaned; very small volumes are injected at targeted points (e.g., vestibule/posterior fourchette or submucosal plane along the lower vaginal wall) according to symptoms. Most describe pressure or sting for a few seconds per injection; topical anaesthetic can be used at the vestibule. Expect brief spotting, fullness or achiness for 24–72 hours. You’ll be advised to keep skincare simple (lukewarm water or bland emollient as a soap substitute), wear breathable underwear, and pause high-friction activity and penetrative sex until comfortable—often 2–7 days.

Benefits and limits. Some women report easier initial penetration, calmer sting, fewer “air-trapping” moments and a steadier sense of support at the entrance after a short PRP series. However, published studies are generally small, uncontrolled or short-term, sometimes mixing indications (GSM, SUI, scar pain). That means effect sizes and durability are uncertain, and results vary. PRP cannot reposition a perineal scar or correct levator avulsion; if those are the drivers, scar therapy, uro-gynae input or surgical review are more appropriate. If dryness and “paper-cut” fissures dominate, friction control and local oestrogen usually outperform injections.

Safety and selection. Because PRP is autologous, allergy risk is low, but bruising, swelling, transient flare of soreness, spotting and rare infection can occur. Defer treatment with active BV/thrush/UTI, malodorous discharge, fever, new post-menopausal bleeding, or soon after pelvic/perineal surgery without clearance. Use clinical caution with platelet disorders, anticoagulants, immunosuppression or poorly controlled pain conditions; a pain-dominant/overactive pelvic floor pattern usually needs down-training and psychosexual support before any injection. Devices and injectables should be UKCA/CE-marked for intimate use and delivered within intended purpose.

Realistic expectations and review. Where used, many clinics suggest a short series (often 2–3 sessions, 4–8 weeks apart). Outcomes should be judged on daily-life change: fewer fissures/micro-tears, less sting, reduced air-trapping, steadier tampon retention, easier speculum exams. If gains are modest, stopping is reasonable. As evidence is still developing, long-term maintenance is individualised rather than routine.